Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

ASX:GYG
ASX:GYGHospitality

Why Guzman y Gomez (ASX:GYG) Is Down 5.7% After Paying Dividends Despite FY26 Net Loss

Guzman y Gomez Limited recently reported full-year 2026 results showing sales of A$520.4 million and a net loss of A$26.7 million, while also announcing both a fully franked ordinary dividend of A$0.262 per share and a fully franked special dividend of A$0.144 per share, payable on 30 September 2026. At the same time, the company outlined plans to open 35 new Australian restaurants in Fiscal Year 2027, with the incremental fourth-quarter openings expected to have only a limited impact on...
NYSE:ONTO
NYSE:ONTOSemiconductor

Onto Innovation (ONTO) Stock Stays Reasonable Despite Its 243% Five Year Run

Onto Innovation has delivered very strong returns over the past five years, yet the stock now screens as fairly valued on an intrinsic value basis, while market multiples suggest it leans expensive. For investors, the question is whether the recent share price level already reflects much of the good news that has driven Onto Innovation higher. Onto Innovation has returned 243.5% over the past five years, which puts extra focus on whether the current price leaves enough room for further value...
SEHK:2652
SEHK:2652Pharmaceuticals

CF PharmTech (SEHK:2652) Stock Pressured By Widening Losses And Thin Profit Clarity

CF PharmTech stock has already been under pressure, with the share price down about 31% over the past three months, and today’s earnings give investors a clear reason why. The market is reacting to a story that is not about revenue size; it is about profits that have slipped into a loss again. The headline for this half is simple. CF PharmTech generated revenue of C¥210.154 million but reported a net loss of C¥10.506 million and a loss per share. That profit squeeze lands on a stock already...
NYSE:FIX
NYSE:FIXConstruction

Comfort Systems USA (FIX) Stock May Trade At A Discount Despite Very Large Share Price Gains

Comfort Systems USA has delivered extremely strong long term share price returns, yet the stock still screens as undervalued on both an intrinsic value estimate and on market multiples, which is an unusual combination for a company with this track record. The Discounted Cash Flow (DCF) intrinsic value estimate currently sits well above the market price, while broader valuation checks also lean cheap. Over the past 5 years, Comfort Systems USA has produced a very large gain for shareholders,...
NasdaqGS:INTC
NasdaqGS:INTCSemiconductor

Intel (INTC) Stock May Be 5% Overvalued As New AI Chips Debut

Intel stock has delivered very strong gains over the past year, yet the valuation signals are mixed, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a share price that is slightly above fair value while market multiples still screen the stock as undervalued. That split leaves investors weighing a powerful price move against a broader scoring framework that currently leans expensive. Intel has returned 267.6% over the past year, which puts extra focus on whether...
NYSE:PSX
NYSE:PSXOil and Gas

Phillips 66 (PSX) Nears Cost Goal As Valuation Questions Come Into Focus

Cost reduction progress puts Phillips 66 in focus Phillips 66 (PSX) is back on investor radars after reporting second quarter 2026 refining controllable costs of about $5.57 per barrel, almost in line with its 2027 target of $5.50. The company links this progress to more than 200 expense focused initiatives in its refining operations. For investors, the update raises fresh questions about how a leaner cost base could affect Phillips 66 profit resilience and capital allocation over time. The...
SEHK:1196
SEHK:1196Trade Distributors

Is Realord Technology (SEHK:1196) Overvalued After Its Half Year Results And Share Price Jump?

Realord Technology (SEHK:1196) has released half year results to June 30, 2026, showing sales of HK$19.31 million, revenue of HK$278.24 million, and a narrowed net loss of HK$464.78 million compared with a year earlier. The half year update on Realord Technology appears to have coincided with a sharp short term shift in sentiment. The 1 month share price return of 35.47% and 7 day return of 18.80% contrast with a year to date share price decline of 29.24% and a 1 year total shareholder return...
ASX:BET
ASX:BETHospitality

BetMakers Technology Group (ASX:BET) Shares Chase Margin Gains Before Profit Arrives

Betmakers Technology Group went into this result with the stock at A$0.21, up strongly over the past month but softer in the last week. That price move suggests optimism has been building. The numbers now force a sharper focus on the main strain in the story. The company is still loss making on a trailing basis, with earnings from continuing operations of A$5.2 million in the red. The headline this time is simple. Revenue in the wagering technology business is holding near A$92.6 million, yet...
KOSE:A005930
KOSE:A005930Tech

Samsung Electronics (KOSE:A005930) Stock Still Looks Below Fair Value As Earnings Stay Strong

Samsung Electronics stock has delivered very strong gains over the past three years, and the current valuation checks still suggest the shares lean cheap rather than stretched. The 3 year return of 289.6% points to a stock that has already rewarded investors heavily and raises the bar for what future performance needs to justify. Expectations that Samsung Electronics can sustain healthy cash generation from its core hardware and component businesses support the current share price, while any...
NYSE:PCG
NYSE:PCGElectric Utilities

PG&E (PCG) Faces Wildfire And Capital Plan Questions, Is The Discount Warranted?

PG&E Stock Triggered by Ongoing Wildfire and Capital Plan Concerns PG&E (PCG) stock is back in focus as investors weigh ongoing uncertainty around California's wildfire liability framework and the company’s capital plan tied to data center driven load growth. These issues, along with PG&E’s higher leverage and its path back toward investment grade status, are central to how the stock is being valued today. Over the past year, PG&E has seen pressure build on its share price, with the stock...
TSE:7211
TSE:7211Auto

Why Mitsubishi Motors (TSE:7211) Is Up 9.8% After New EV Software Talks With Honda And Nissan

Honda recently confirmed it has been in talks with Nissan and Mitsubishi Motors about jointly developing a vehicle operating system and onboard computer for future models, with potential deployment from around 2029. This prospective software alliance could reshape how Mitsubishi Motors shares development costs and technology within its existing partnerships, influencing its longer-term competitiveness in connected vehicles. Next, we’ll explore how the potential joint operating system...
NYSE:NU
NYSE:NUBanks

Nu Holdings (NU) Could Be 36% Undervalued On Q1 Revenue Beat

Nu Holdings (NYSE:NU) stock moved after first quarter results showed revenue up 57.6% year on year and 48.9% above analyst expectations. The share price is now US$14.52, about 12.3% higher since the report. Over the past year Nu Holdings has seen mixed momentum, with a 90 day share price return of 21.96% set against a year to date share price decline of 14.51%. The 1 year total shareholder return is slightly negative, while the 3 year total shareholder return of 104.64% points to a much...
NYSE:VYX
NYSE:VYXSoftware

NCR Voyix (VYX) Stock Looks Expensive Despite Broader Cheap Signals

NCR Voyix has seen its share price fall sharply over the past few years, yet the stock still screens as expensive on market multiples while broader valuation checks lean the other way. For investors looking at NCR Voyix today, the key issue is how to weigh that mixed message against a long spell of weak returns. The stock has declined 67.3% over 5 years, which points to a long period of weak market confidence in NCR Voyix. Expectations for better cash flow from its software and services may...
NYSE:BAC
NYSE:BACBanks

Are Bank of America’s (BAC) New Bond Deals Quietly Redefining Its Tech‑Driven Funding Strategy?

In late August 2026, Bank of America completed several fixed-income offerings totaling roughly US$40.50 million and KRW 30.00 billion across senior unsecured notes with varying maturities, coupons, and callable features, while also preparing for its upcoming BofA India IT Call Series on September 1, 2026. These bond issues and the India-focused IT call highlight how Bank of America is actively managing its funding mix while leaning into technology and digital capabilities to support future...
NYSE:LU
NYSE:LUConsumer Finance

Where Does Lufax Holding (LU) Valuation Stand After Weaker Half Year Results?

How Lufax Holding’s latest results frame the investment story Lufax Holding (NYSE:LU) recently reported half year 2026 results that showed lower sales and revenue compared with a year earlier, alongside a wider net loss and higher loss per share from continuing operations. For investors, these figures provide a fresh reference point for assessing the company’s current business profile, risk level and potential reward, especially given the stock’s weak share price performance over the past...
OM:HOLM B
OM:HOLM BForestry

Will Holmen’s (OM:HOLM B) Profitability Squeeze Amid Rising Sales Recast Its Core Investment Narrative?

In August 2026, Holmen AB reported second-quarter results showing sales of SEK 5,632 million, modestly higher than a year earlier, while net income eased to SEK 510 million and earnings per share from continuing operations slipped to SEK 3.3. Across the first half of 2026, sales of SEK 11,105 million and lower earnings per share of SEK 7.4 highlighted that profitability, rather than revenue, was the main pressure point for Holmen. With quarterly net income down even as sales inched higher,...
NasdaqGS:UMBF
NasdaqGS:UMBFBanks

UMB Financial (UMBF) Stock Could Be 39% Below Fair Value Despite Fresh Analyst Coverage

UMB Financial has had a strong three year run in the stock market, yet several valuation checks suggest the current share price may still sit below a conservative view of what the business is worth. Recent analyst coverage and the latest intrinsic value work using an Excess Returns model both point to potential upside that the market may not be fully pricing in. Over the past three years, UMB Financial has returned about 130% which signals that investors have already re-rated the stock...
NasdaqGS:NWL
NasdaqGS:NWLConsumer Durables

Will Newell’s US$600 Million Refinancing and EXPO XL Launch Shift Newell Brands' (NWL) Narrative?

In August 2026, Newell Brands Inc. issued US$600,000,000 of 6.250% senior notes due 2031 to refinance its 6.375% senior notes due 2027 and partially repay its asset-based revolving credit facility, while also introducing the EXPO XL dry-erase marker aimed at improving classroom visibility and accessibility. The combination of a sizeable debt refinancing with restrictive covenants and a classroom-focused EXPO XL launch highlights Newell’s focus on tightening its balance sheet while seeking...
CPSE:HLUN B
CPSE:HLUN BPharmaceuticals

H. Lundbeck (CPSE:HLUN B) After Strong Q2 Results Is The Stock A Bargain Or Priced Right

Why H. Lundbeck stock is in focus after Q2 2026 H. Lundbeck (CPSE:HLUN B) is back on investor radars after reporting second quarter 2026 earnings, with higher sales and net income, and confirming full year guidance supported by demand for its key pharmaceutical brands. Following the earnings release and confirmed 2026 guidance, H. Lundbeck’s share price, now at DKK42.2, has seen a modest 1-day share price return of 1.88%, while the 90-day share price return is down 4.57%. However, the 3-year...
SEHK:305
SEHK:305Auto Components

Wuling Motors Holdings (SEHK:305) Stock Revenue Holds As Margins Tighten

Wuling Motors Holdings came into this earnings print with a flat 7 day share price and a modest slide over the past quarter, yet the stock closed at HK$0.395 today with little drama. The headline is quieter than the long term story. Revenue for the first half of 2026 held around ¥4,000.5m, but net income slipped to ¥26.2m and the trailing net margin sat at 0.8%. For an auto components group often viewed through its past earnings growth and a 17x P/E, this report puts pressure on the profit...
TASE:AZRM
TASE:AZRMConsumer Durables

Azorim Investment Development And Construction (TASE:AZRM) Reported Fresh Earnings, Is The Valuation Still About Right?

What Azorim-Investment Development & Construction’s Latest Earnings Tell You Azorim-Investment Development & Construction (TASE:AZRM) recently reported its Q2 and first half 2026 results, giving investors fresh detail on revenue, sales and earnings per share from its ongoing operations. The company posted Q2 revenue of ₪375.72 million and net income of ₪53.9 million, with basic EPS from continuing operations of ₪0.25. Sales for the quarter were ₪28.75 million. Over the first six months of...
NYSE:ESTC
NYSE:ESTCSoftware

Elastic (ESTC) Raises Outlook After Earnings Beat As Valuation Debate Heats Up

Elastic (NYSE:ESTC) shares moved after the company reported better than expected Q1 fiscal 2027 results, raised full year revenue and earnings guidance, and highlighted stronger monetization of its AI and observability offerings. Elastic's 1 day share price return declined 2.36% to US$97.55. However, the 7 day share price return of 17.19% and 30 day share price return of 48.27% point to strong recent momentum following the earnings beat. In contrast, the 1 year total shareholder return of...
NYSE:JNJ
NYSE:JNJPharmaceuticals

Johnson & Johnson (JNJ) Stock May Trade At A Discount As Europe Backs Tecvayli

Johnson & Johnson stock has delivered a 3 year total return of 80.4%, yet the latest valuation checks send mixed signals, with the Discounted Cash Flow (DCF) intrinsic value pointing to upside while market based multiples suggest the shares are not cheap. The 80.4% gain over the past 3 years points to strong shareholder rewards that may already reflect a lot of optimism in Johnson & Johnson. Recent approvals for TECVAYLI in Europe and IMAAVY in the US can support long term cash flow...
NasdaqCM:LXRX
NasdaqCM:LXRXPharmaceuticals

Why Lexicon Pharmaceuticals (LXRX) Is Back In The Spotlight

Lexicon Pharmaceuticals (LXRX) has drawn fresh attention after new SOLOIST-WHF Phase 3 post hoc data on sotagliflozin were shared at ESC Congress 2026. The findings reinforce consistent efficacy and safety across baseline blood pressure in high risk heart failure patients. Despite the new SOLOIST-WHF data, Lexicon Pharmaceuticals’ share price has softened in the very short term, with a 1-day share price return of 1.75% and a 7-day share price return of 3.85%. However, a 90-day share price...